27 November 2025
Voice of the Voiceless is a collaboration between people who receive opioid substitution therapy (OST) for opioid dependence, University of Bristol academics (Dr Vicky Carlisle, Dr Adam Holland, Dr Jenny Scott), Bristol City Council (Ashley Ward), Bristol Drugs Project (Lydia Plant, Lianna Telfer), Developing Health & Independence (Nick Booth), and Harm Reduction Mothers2Mothers (Anna Millington).
In 2024, the team worked together with a graphic designer to co-produce a booklet that aims to: reduce stigma for people who receive opioid substitution treatment; empower them in their interactions in pharmacies; and foster mutual compassion and respect between pharmacy staff and people who receive OST. Here Dr Vicky Carlisle, Research Fellow at the University of Bristol, blogs about the project.
Voice of the Voiceless booklet cover image
OST (with methadone or buprenorphine) is prescribed for opioid dependence. Broadly, the aim is to provide individuals with stability and relief from withdrawal symptoms, and to reduce reliance on street drugs. OST is associated with a range of benefits, including a reduction in the transmission of Hepatitis C and HIV, improved physical and mental health, improvements in quality of life, and more stable living circumstances. OST is also highly effective in reducing drug related deaths, which are at record levels in England.
These benefits however are undermined by barriers to retention and engagement; estimates suggest only about half of people who may benefit from OST are receiving it in England. Stigma is cited as a key barrier to services. People who are prescribed OST often have to attend a pharmacy daily and, at least at first, are usually supervised consuming their dose. Pharmacy staff therefore see the person regularly, yet have often received little training in how to interact with people in receipt of OST, many of whom have experienced trauma and exclusion. To maximise engagement and retention in OST, it is vital that interventions are developed which address the stigma that people who receive OST experience, including that experienced in pharmacies.
In May 2023 we held a full-day workshop in Bristol with thirteen people with lived experience of stigma related to their drug use and fourteen professionals working across drugs services and other, related sectors in Bristol. We worked with a professional facilitator, Jose Barco who expertly led a number of activities throughout the day, which resulted in us collaboratively identifying policy, practice and research needs in relation to stigma towards people who use drugs in Bristol. Stigma in pharmacies in relation to receiving OST was identified as a key issue to address, which led to the Voice of the Voiceless project.
We ran three in-person workshops between February and July 2024 with people with lived experience, academics and pharmacy staff.
We adopted the following principles of co-production, as recommended by NIHR INVOLVE:
The first workshop took place at The Community Farm, near Chew Magna – a beautiful setting to start to get to know each other, build trust and develop shared understandings for the work. This involved a wood burner, marshmallows, lots of tea and (a now legendary) carrot cake. By the end of the first session, we had sketched out an idea for what we wanted to achieve by the end of the project. The group also discussed their positive and negative experiences of receiving OST in pharmacies. Most importantly, we really bonded and felt like a team by the end of the day.
During the second session at Barton Hill Micro-campus, we focussed on the content of the booklet. One of the lived experience members suggested the name ‘Voice of the Voiceless’ for the group, which powerfully illustrated what we were trying to achieve and how the group saw themselves previously.
The group felt that it was important to represent both positive and negative experiences as, when care was good, it was noted to have a hugely positive impact on the lives of people who receive OST. The lived experience members chose to share their stories as vignettes in the booklet and these were interspersed with ‘rights and responsibilities’ for both pharmacy staff and people who receive OST. The aims of this were to:
We communicated the style and content to the graphic designer, who then produced proofs for us to look at during the final, in-person session.
During the third and final workshop, we refined the content of the booklet and the images. These were then shared with the group via email until we had an agreed draft.
Finalising the Voice of the Voiceless booklet outside at the Barton-Hill Micro-campus
Participants described the co-production process as empowering and inclusive. Getting out of the city for the first workshop was particularly valued and the relaxed, informal setting really helped the group to bond. Everyone felt proud of the final output and were keen to stay connected to work on future projects.
The booklet is now being disseminated across the United Kingdom, with plans to evaluate its impact and explore further training and engagement opportunities.
The booklet is available for download.
This work was funded by the University of Bristol’s Participatory Research Fund.
If you would like more information about this project or would like to work with the Voice of the Voiceless lived experience members on your project, please contact Dr Vicky Carlisle.
We are always keen to hear from potential future collaborators who share our commitment to and passion for ending stigma towards people who use drugs and those who receive opioid substitution therapy.
Read our letter about the booklet in the Pharmaceutical Journal.
For related campaigns and resources, see: